Harnessing artificial intelligence and machine learning for accelerating drug repurposing in hepatitis B virus therapy
Discover Artificial Intelligence · 19.04.2026 · 6 (1)
DOI: 10.1007/s44163-026-01263-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Discover Artificial Intelligence, online erschienen am 19.04.2026. Verfasst von Samuel Chima Ugbaja und 7 weiteren Autor:innen. Die Arbeit nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ugbaja, S. C., Dangana, R. S., Sanusi, I. O., Ibitoye, O. A., Nkungu, A., Mafuleka, L., Okpeku, M., & Gqaleni, N. (2026). Harnessing artificial intelligence and machine learning for accelerating drug repurposing in hepatitis B virus therapy. Discover Artificial Intelligence, 6(1). https://doi.org/10.1007/s44163-026-01263-7
Vancouver
Ugbaja SC, Dangana RS, Sanusi IO, Ibitoye OA, Nkungu A, Mafuleka L, et al. Harnessing artificial intelligence and machine learning for accelerating drug repurposing in hepatitis B virus therapy. Discover Artificial Intelligence. 2026;6(1). doi:10.1007/s44163-026-01263-7
BibTeX
@article{Ugbaja2026,
author = {Ugbaja, Samuel Chima and Dangana, Reuben Samson and Sanusi, Idris Olatunji and Ibitoye, Olukayode Adebola and Nkungu, Asekho and Mafuleka, Lwandiswa and Okpeku, Moses and Gqaleni, Nceba},
title = {Harnessing artificial intelligence and machine learning for accelerating drug repurposing in hepatitis B virus therapy},
journal = {Discover Artificial Intelligence},
year = {2026},
volume = {6},
number = {1},
doi = {10.1007/s44163-026-01263-7}
}
EUVIMED